PharmaTimes Business Insights
Do you have a new product, new business focus, or a company to showcase?
Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy and photos, or utilise the services of our professional writers and/or photographer to ensure you communicate the best possible message to your audience.
So why not talk to our business development team about Business Insight opportunities with PharmaTimes. After all, a Business Insight in PharmaTimes Magazine offers a unique opportunity to raise your company’s profile in the pharmaceutical world.
Call 020 8478 9105 or email Donna to discuss your requirements.
Doctors.net.uk, May 2013
Using an integrated approach to build relationships with customers
Doctors still want to engage with pharma companies – but they want a different relationship from those of the past, says Simon Grime, managing director, communications, Doctors.net.uk. Integrating independent online physician networks into the mix can help drive this measurable change
Oberoi Consulting, May 2013
Making sense of the data
Data are nothing on their own, says Oberoi Consulting’s managing director Kavita Oberoi. Instead they should feed the improvement of care pathways and patient outcomes to effect real change
Pharmexx, December 2012
Pharmexx – Does pharma make it too hard for its customers to work with them?
In the post-transactional NHS the industry needs to engage with its customer. Pharmexx recently provided a platform for ideas on how pharma can partner for outcomes
Accenture, November 2012
Companies join forces to improve R&D
Ten pharmaceutical companies have joined together with Accenture to form an organisation to identify and solve the R&D issues facing the industry, and help speed drugs to market
Sanofi, November 2012
Patient safety "part of the DNA"
Sanofi’s Dr John Solomon talks to PharmaTimes Magazine about instilling a wider culture of patient safety and public health across the business, which sits at the heart of corporate social responsibility
PAN, September 2012
PAN comes of age
One agency that can deliver digial as well as print media is what is driving PAN forward in its 21st year
Patient Connect, September 2012
How the Patient Connect service can optimise PPI care (advertisement)
Sanofi, July/August 2012
Driving engagement through CSR, at Sanofi
Corporate social responsibility binds companies to the communities they serve, and binds employees to the company by acting as a repository of shared values
Making diabetes treatment count with Patient Connect
Poor medication adherence rates exacerbate the problems and cost of managing diabetes. Health Information can help support patients and ensure their medication is used optimally, reducing the cost and treatment burden on the NHS and improving medicines use
Health Information, June 2012
Sick of anti-emetics: how Patient Connect Alerts helped to square the circle
A point-of-dispensing alert service to help improve patient pain relief led to a significant increase in adherence and improved symptom relief. So just how was this achieved?
McCann Torre Lazur
Collaborate and connect: McCann Torre Lazur
The company may have rebranded to become mccann torre lazur, showing its closer connection to “the mothership” mccann, but it’s the ethos of collaboration behind it that sets the agency apart, says mccann health managing director Phil Bartlett
Motivating for mutual value: PI Partnership
With revised branding, an increasingly global profle and a raft of innovative techniques to educate and motivate sales and marketing teams in more relationship-oriented strategies, Pi Partnership is helping clients deliver mutual value and cost-effciency to health systems that have long since closed their doors on the easy sell
Sanofi, May 2012
Value through transformation: Sanofi's diversified offering
In little over three years Sanofi has moved from a highly concentrated, mega-brands business to a diversified healthcare company providing "holistic solutions focussed on patients' needs".
Health Information, May 2012
Stemming the costs of non-adherence: Health Information's Patient Connect Service
40%-70% of patients stop taking their life-long medicines withing six months, says Zoe Barker, legal and commercial director of Health Information. This leads to premature deaths, compromised quality of life and lost patients for industry. But a new service from Health Information is turning that around, with some compelling results.
Zenopa, March 2012
Zenopa Executive climbs the recruitment ladder
Having carved itself a distinctive niche in the digital media space, Zenopa Executive has done more than simply move away from the business of traditional vacancy marketing
DJM Digital, February 2012
You can have fun: DJM pushes the digital envelope
Digital media have made significant inroads into pharmaceutical marketing and communications over recent years. But the potential goes
a lot further than websites and smartphones, says Dominic Marchant, founder and managing director of DJM Digital
Galen, January 2012
Galen takes global leap into niche oncology
Galen’s successful transition from high-volume, low-value generics to niche oncology is the first step in a programme of diversification that is taking the company beyond its traditional UK/Ireland border
15 Healthcare - Brokering value in the NHS
Almirall - Delivering the difference
Masters - Improving lives through patient access
Novo Nordisk - Leading the Novo Nordisk way
Takeda UK - charts a new course for growth
Lundbeck - Lundbeck goes local with new sales organisation
Medea Communications - Roots and new shoots: Medea Communications
Lundbeck - At the core of it
IMS - Grasping the new realities of launch excellence
If you would like to see other companies covered then why not let us know? Email: email@example.com.
All photography by Magnus Rew http://magnusrew.co.uk.